Page last updated: 2024-08-21

evans blue and Anterior Cerebral Circulation Infarction

evans blue has been researched along with Anterior Cerebral Circulation Infarction in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Cui, W; Feng, Y; Liu, F; Sang, J; Wu, Z; Xiao, X; Yan, S; Yang, M; Ye, S1
Fu, FH; Hou, J; Jiang, WL; Tian, JW; Zhu, HB1
Akyüz, F; Durmaz, R; Inal, M; Isiksoy, S; Kanbak, G; Tel, E; Yücel, F1
Baba, A; Itoh, S; Koyama, Y; Matsuda, T; Matsui, S; Osakada, M1
Bahcekapili, N; Gökkusu, C; Kuru, A; Uzüm, G; Ziylan, YZ1
Hosseinzadeh, F; Sadogh, T; Vakili, A1
Cheng, JT; Hsieh, FJ; Hsieh, YH; Hsu, WM; Lai, DM; Lee, CC; Li, H; Tu, YK; Tzeng, YS1
Buemi, M; Fodale, V; Grasso, G; Iacopino, DG; Meli, F; Sfacteria, A1

Other Studies

8 other study(ies) available for evans blue and Anterior Cerebral Circulation Infarction

ArticleYear
Evans Blue Might Produce Pathologically Activated Neuroprotective Effects via the Inhibition of the P2X4R/p38 Signaling Pathway.
    Cellular and molecular neurobiology, 2021, Volume: 41, Issue:2

    Topics: Animals; Behavior, Animal; Brain Infarction; Cell Death; Cell Line; Evans Blue; Infarction, Middle Cerebral Artery; Iodoacetic Acid; Male; Mice; Models, Biological; Molecular Docking Simulation; Neurons; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley; Receptors, Purinergic P2X4; RNA, Messenger; Signal Transduction

2021
Neuroprotective efficacy and therapeutic window of Forsythoside B: in a rat model of cerebral ischemia and reperfusion injury.
    European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3

    Topics: Animals; Anti-Inflammatory Agents; Antigens, Nuclear; Brain Infarction; Brain Ischemia; Caffeic Acids; Disease Models, Animal; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Glucosides; Glycosides; Leukocytes; Male; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; NF-kappa B; Peroxidase; Rats; Rats, Sprague-Dawley; Reperfusion Injury

2010
Lazaroid attenuates edema by stabilizing ATPase in the traumatized rat brain.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2003, Volume: 30, Issue:2

    Topics: Animals; Blood-Brain Barrier; Body Water; Brain Infarction; Brain Injuries; Ca(2+) Mg(2+)-ATPase; Cell Survival; Chromans; Edema; Endothelium, Vascular; Evans Blue; Lipid Peroxidation; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Piperazines; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Synaptosomes; Treatment Outcome

2003
The selective Na+-Ca2+ exchange inhibitor attenuates brain edema after radiofrequency lesion in rats.
    European journal of pharmacology, 2004, Apr-12, Volume: 489, Issue:3

    Topics: Aniline Compounds; Animals; Brain Chemistry; Brain Edema; Brain Infarction; Catheter Ablation; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Fluorescein; Injections, Intravenous; Male; Phenyl Ethers; Rats; Rats, Wistar; Serum Albumin; Sodium-Calcium Exchanger

2004
The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats.
    Life sciences, 2007, Mar-13, Volume: 80, Issue:14

    Topics: Animals; Blood-Brain Barrier; Brain Infarction; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Disease Models, Animal; Drug Administration Schedule; Epoetin Alfa; Erythropoietin; Evans Blue; Lipid Peroxidation; Male; Neuroprotective Agents; Rats; Rats, Wistar; Recombinant Proteins; Reperfusion Injury; Thiobarbituric Acid Reactive Substances

2007
Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
    Brain research, 2007, Sep-19, Volume: 1170

    Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Infarction; Cerebral Arteries; Coloring Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Evans Blue; Guanidines; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Rats; Rats, Wistar; Reperfusion Injury; Time Factors; Treatment Outcome

2007
Angiopoietin-like protein 1 decreases blood brain barrier damage and edema following focal cerebral ischemia in mice.
    Neurochemistry international, 2008, Volume: 52, Issue:3

    Topics: Angiopoietin-Like Protein 1; Angiopoietin-like Proteins; Angiopoietins; Animals; Blood-Brain Barrier; Brain Edema; Brain Infarction; Brain Ischemia; Cerebral Arteries; Evans Blue; Glial Fibrillary Acidic Protein; Humans; Intercellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Microcirculation; Promoter Regions, Genetic

2008
Neuroprotection by erythropoietin administration after experimental traumatic brain injury.
    Brain research, 2007, Nov-28, Volume: 1182

    Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Infarction; Brain Injuries; Disease Models, Animal; Erythropoietin; Evans Blue; Functional Laterality; Humans; Male; Neurologic Examination; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reaction Time; Recombinant Proteins; Time Factors

2007